ZA931700B - Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients - Google Patents
Use of L-carnitine for treating carnitine-depleted HIV-seropositive patientsInfo
- Publication number
- ZA931700B ZA931700B ZA931700A ZA931700A ZA931700B ZA 931700 B ZA931700 B ZA 931700B ZA 931700 A ZA931700 A ZA 931700A ZA 931700 A ZA931700 A ZA 931700A ZA 931700 B ZA931700 B ZA 931700B
- Authority
- ZA
- South Africa
- Prior art keywords
- carnitine
- treating
- seropositive patients
- depleted hiv
- depleted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM920165A IT1255039B (en) | 1992-03-11 | 1992-03-11 | USE OF L-CARNITINE IN THE TREATMENT OF HIV-SEROPOSITIVE PATIENTS PRESENTING CARNITINE DEFICIT. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA931700B true ZA931700B (en) | 1993-11-16 |
Family
ID=11400792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA931700A ZA931700B (en) | 1992-03-11 | 1993-03-10 | Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0560275A1 (en) |
JP (1) | JPH069387A (en) |
KR (1) | KR0148350B1 (en) |
IT (1) | IT1255039B (en) |
ZA (1) | ZA931700B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1277897B1 (en) * | 1995-08-03 | 1997-11-12 | Mendes Srl | USE OF L-CARNITINE, ITS DERIVATIVES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS IN COMBINATION WITH ANTIRETROVIRAL DRUGS TO REDUCE |
LV13544B (en) | 2005-08-15 | 2007-05-20 | Grindeks As | Pharmaceutical composition containing reverse transcriptase inhibitor and meldonium |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2921852A1 (en) * | 1979-05-29 | 1980-12-11 | Fresenius Chem Pharm Ind | LIPID LOWERING AGENT |
IT1143214B (en) * | 1981-07-09 | 1986-10-22 | Sigma Tau Ind Farmaceuti | ACIL DERIVED FROM CARNITINE AS IMMUNOMODULATOR |
-
1992
- 1992-03-11 IT ITRM920165A patent/IT1255039B/en active IP Right Grant
-
1993
- 1993-03-09 EP EP93103740A patent/EP0560275A1/en not_active Withdrawn
- 1993-03-10 ZA ZA931700A patent/ZA931700B/en unknown
- 1993-03-11 KR KR1019930003612A patent/KR0148350B1/en not_active IP Right Cessation
- 1993-03-11 JP JP5050584A patent/JPH069387A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
ITRM920165A0 (en) | 1992-03-11 |
IT1255039B (en) | 1995-10-13 |
JPH069387A (en) | 1994-01-18 |
KR0148350B1 (en) | 1998-11-02 |
KR930019207A (en) | 1993-10-18 |
ITRM920165A1 (en) | 1993-09-11 |
EP0560275A1 (en) | 1993-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9203626D0 (en) | Dipyridamole preparatives for treatment of proliferative deseases | |
HU9300536D0 (en) | Compounds of medical effect | |
GB9208921D0 (en) | Electrochemical treatment of surfaces | |
EP0584340A4 (en) | Diagnosis and treatment of various neuralgias | |
IL101410A0 (en) | Formulation for the treatment of cancer | |
EP0577023A3 (en) | Angiotensin-ii receptor-antagonists for the treatment of arrhythmices | |
HU9302183D0 (en) | Medical preparatives for preventing and treating osteoporises after menopausa | |
GB9222260D0 (en) | Skin treatment | |
ZA932303B (en) | Medicament for the treatment of airways inflammation and airways hyperresponsiveness | |
GB9217124D0 (en) | Medical treatment | |
ZA931700B (en) | Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients | |
GB9202196D0 (en) | Method of treatment | |
GB9216360D0 (en) | Treatment of blood | |
GB9201193D0 (en) | Treatment of liquids | |
GB2220652B (en) | Treatment of pastures | |
GB2266241B (en) | Treatment of pastures | |
GB9201391D0 (en) | Method of treatment | |
GB9218773D0 (en) | Skin treatment | |
GB9207595D0 (en) | Treatment of pastures | |
GB9212535D0 (en) | Treatment of boimass | |
BG95257A (en) | Preparation and method for the treatment of paradontosis | |
BG98001U (en) | Medicament for the treatment of hyperkeratotic conditions of the skin | |
GB9222195D0 (en) | Medical treatment | |
GB9204062D0 (en) | Medical treatment | |
BG96534A (en) | Method and device for therapy of patients |